Institute for Computer Research seminar
“The business method patent is dead! Long live the business method patent!”
Mark Penner, Partner
Wednesday, October 20, 2010
3:30pm to 4:30pm
DC 1304, Davis Centre, University of Waterloo
The University of Waterloo is pleased to welcome Mark Penner, Partner at the law firm of Fasken Martineau, for a presentation of interest to inventors, business strategists and patent experts.
Mark will be giving a presentation entitled, “The Business Method Patent is Dead! Long Live the Business Method Patent!” highlighting the recent U.S. Supreme Court decision regarding “Bilski”. The Bilski decision may weaken some business method patents, because the Supreme Court reasoned about tests for the validity of business method patents, including concepts such as processes tied to a particular machine or apparatus and processes to transform a particular article into a different state or thing. If the purpose of patents is to protect advances in the application of science, does this extend to methods of conducting business and the structure of business transactions?
Topics to be discussed include
- Bilski decision and the patentability of business methods abstract ideas
- Canada's stance on business method patents
- Why Bilski is important - the industries and areas of business (financial, sales & marketing, e-commerce) it affects
- Potential benefits/risks with the patent process; looking at the process pre- and post-Bilski
Who should attend
The presentation will; be of interest to anyone with a patent portfolio or inventions/developments for which patent protection will be required.
Mark is a Partner in the Technology and Intellectual Property Practice Group at Fasken Martineau. His expertise includes acquisition, protection and enforcement of intellectual property rights in the chemical, pharmaceutical and biotechnology areas. Also a recognized patent and trade-mark agent, Mark has extensive experience with preparing infringement, validity, freedom to operate and patentability opinions in the life sciences. On the enforcement side, Mark has been involved in Federal Court proceedings involving patent infringement and validity as well as Notice of Compliance proceedings under the Patented Medicines (Notice of Compliance) Regulations. His practice also involves the IP aspects of corporate transactions (e.g. financing, mergers & acquisitions and joint ventures) such as protection of confidential information, trade secrets and know how, conducting due diligence, as well as technology acquisition and licensing.
200 University Avenue West
Waterloo, ON N2L 3G1